製品の概要

  • 製品名
    Anti-Cytokeratin antibody [CK-cocktail]
    Cytokeratin 一次抗体 製品一覧
  • 製品の詳細
    Mouse monoclonal [CK-cocktail] to Cytokeratin
  • アプリケーション
    適用あり: IHC-P, IHC-Fr, ICCmore details
  • 種交差性
    交差種: Human
  • 免疫原

    Human epidermal Cytokeratin.

  • ポジティブ・コントロール
    • Human skin, lung, colon, prostate, or any GI tissue or cancer tissues.
  • 特記事項

    This product was changed from ascites to tissue culture supernatant on 15th June 2017.  Lot numbers higher than GR309863-1 will be from tissue culture supernatant.  Please note that the dilutions may need to be adjusted accordingly.

製品の特性

  • 製品の状態
    Liquid
  • 保存方法
    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • バッファー
    pH: 7.40
    Preservative: 0.09% Sodium azide
    Constituents: 98% PBS, 1% BSA
  • 精製度
    Tissue culture supernatant
  • ポリ/モノ
    モノクローナル
  • クローン名
    CK-cocktail
  • アイソタイプ
    IgG1
  • 軽鎖の種類
    kappa
  • 研究分野

アプリケーション

Our Abpromise guarantee covers the use of ab115959 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
IHC-P 1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
IHC-Fr 1/50 - 1/100.
ICC Use at an assay dependent concentration.

Use at an assay dependent concentration

ターゲット情報

  • 機能
    May regulate the activity of kinases such as PKC and SRC via binding to integrin beta-1 (ITB1) and the receptor of activated protein kinase C (RACK1/GNB2L1).
  • 組織特異性
    The source of this protein is neonatal foreskin. The 67-kDa type II keratins are expressed in terminally differentiating epidermis.
  • 関連疾患
    Defects in KRT1 are a cause of bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800]; also known as epidermolytic hyperkeratosis (EHK) or bullous erythroderma ichthyosiformis congenita of Brocq. BCIE is an autosomal dominant skin disorder characterized by widespread blistering and an ichthyotic erythroderma at birth that persist into adulthood. Histologically there is a diffuse epidermolytic degeneration in the lower spinous layer of the epidermis. Within a few weeks from birth, erythroderma and blister formation diminish and hyperkeratoses develop.
    Defects in KRT1 are the cause of ichthyosis hystrix Curth-Macklin type (IHCM) [MIM:146590]. IHCM is a genodermatosis with severe verrucous hyperkeratosis. Affected individuals manifest congenital verrucous black scale on the scalp, neck, and limbs with truncal erythema, palmoplantar keratoderma and keratoses on the lips, ears, nipples and buttocks.
    Defects in KRT1 are a cause of palmoplantar keratoderma non-epidermolytic (NEPPK) [MIM:600962]. NEPKK is a dermatological disorder characterized by focal palmoplantar keratoderma with oral, genital, and follicular lesions.
    Defects in KRT1 are a cause of ichthyosis annular epidermolytic (AEI) [MIM:607602]; also known as cyclic ichthyosis with epidermolytic hyperkeratosis. AEI is a skin disorder resembling bullous congenital ichthyosiform erythroderma. Affected individuals present with bullous ichthyosis in early childhood and hyperkeratotic lichenified plaques in the flexural areas and extensor surfaces at later ages. The feature that distinguishes AEI from BCIE is dramatic episodes of flares of annular polycyclic plaques with scale, which coalesce to involve most of the body surface and can persist for several weeks or even months.
    Defects in KRT1 are the cause of palmoplantar keratoderma striate type 3 (SPPK3) [MIM:607654]; also known as keratosis palmoplantaris striata III. SPPK3 is a dermatological disorder affecting palm and sole skin where stratum corneum and epidermal layers are thickened. There is no involvement of non-palmoplantar skin, and both hair and nails are normal.
  • 配列類似性
    Belongs to the intermediate filament family.
  • 翻訳後修飾
    Undergoes deimination of some arginine residues (citrullination).
  • 細胞内局在
    Cell membrane. Located on plasma membrane of neuroblastoma NMB7 cells.
  • Information by UniProt
  • 参照データベース
  • 別名
    • 67 kDa cytokeratin antibody
    • CK-1 antibody
    • CK1 antibody
    • Cytokeratin 1 antibody
    • Cytokeratin 19 antibody
    • Cytokeratin 8 antibody
    • Cytokeratin-1 antibody
    • EHK antibody
    • EHK1 antibody
    • epidermolytic hyperkeratosis 1 antibody
    • EPPK antibody
    • Hair alpha protein antibody
    • K1 antibody
    • K2C1_HUMAN antibody
    • KB1 antibody
    • Keratin 1 antibody
    • keratin 1, type II antibody
    • Keratin 19 antibody
    • Keratin 8 antibody
    • Keratin antibody
    • keratin, type II cytoskeletal 1 antibody
    • Keratin-1 antibody
    • Krt1 antibody
    • KRT19 antibody
    • KRT1A antibody
    • KRT8 antibody
    • KRTA antibody
    • NEPPK antibody
    • type II cytoskeletal 1 antibody
    • Type-II keratin Kb1 antibody
    see all

Anti-Cytokeratin antibody [CK-cocktail] (ab115959) 使用論文

This product has been referenced in:
  • Lefevre JG  et al. Self-organisation after embryonic kidney dissociation is driven via selective adhesion of ureteric epithelial cells. Development 144:1087-1096 (2017). Read more (PubMed: 28174247) »
  • Combes AN  et al. Cap mesenchyme cell swarming during kidney development is influenced by attraction, repulsion, and adhesion to the ureteric tip. Dev Biol 418:297-306 (2016). ICC/IF . Read more (PubMed: 27346698) »

See all 3 Publications for this product

Product Wall

Thank you for your inquiry. I have confirmed with the laboratory that this Cytokeratin cocktail contains 5 different clones. The immunogen used to generate these was Human epidermal keratin. The expected MW of cytokeratins are: CK1 (67), CK2 (65.5...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録